Your browser doesn't support javascript.
loading
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.
Reardon, David A; Brandes, Alba A; Omuro, Antonio; Mulholland, Paul; Lim, Michael; Wick, Antje; Baehring, Joachim; Ahluwalia, Manmeet S; Roth, Patrick; Bähr, Oliver; Phuphanich, Surasak; Sepulveda, Juan Manuel; De Souza, Paul; Sahebjam, Solmaz; Carleton, Michael; Tatsuoka, Kay; Taitt, Corina; Zwirtes, Ricardo; Sampson, John; Weller, Michael.
Afiliação
  • Reardon DA; Dana-Farber/Harvard Cancer Center, Boston, Massachusetts.
  • Brandes AA; AUSL-IRCCS Institute of Neurological Sciences, Bologna, Italy.
  • Omuro A; Department of Neurology and Yale Cancer Center, Yale University, New Haven, Connecticut.
  • Mulholland P; University College London Hospitals, London, United Kingdom.
  • Lim M; The Johns Hopkins Hospital, Baltimore, Maryland.
  • Wick A; Neurology Clinic, University of Heidelberg, National Center for Tumor Diseases, Heidelberg, Germany.
  • Baehring J; Yale School of Medicine, New Haven, Connecticut.
  • Ahluwalia MS; Cleveland Clinic, Cleveland, Ohio.
  • Roth P; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.
  • Bähr O; Dr Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt, Germany.
  • Phuphanich S; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Sepulveda JM; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • De Souza P; University of Wollongong School of Medicine, Wollongong, NSW, Australia.
  • Sahebjam S; Moffitt Cancer Center, University of South Florida, Tampa, Florida.
  • Carleton M; Bristol Myers Squibb, Princeton, New Jersey.
  • Tatsuoka K; Bristol Myers Squibb, Princeton, New Jersey.
  • Taitt C; Bristol Myers Squibb, Princeton, New Jersey.
  • Zwirtes R; Bristol Myers Squibb, Princeton, New Jersey.
  • Sampson J; Duke University Hospital, Durham, North Carolina.
  • Weller M; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.
JAMA Oncol ; 6(7): 1003-1010, 2020 07 01.
Article em En | MEDLINE | ID: mdl-32437507
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Inibidores da Angiogênese / Bevacizumab / Antineoplásicos Imunológicos / Nivolumabe / Inibidores de Checkpoint Imunológico / Recidiva Local de Neoplasia Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Oncol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Inibidores da Angiogênese / Bevacizumab / Antineoplásicos Imunológicos / Nivolumabe / Inibidores de Checkpoint Imunológico / Recidiva Local de Neoplasia Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Oncol Ano de publicação: 2020 Tipo de documento: Article